Previous reports have found that intestinal PPARα deficiency didn't markedly inhibit FA oxidation and ketogenesis (Fig. S5A and S5B), yet it reduced the absorption of dietary fat and improved dyslipidemia and hepatic steatosis23,.24 The gene discussed is PPARA; the disease is metabolic syndrome.